Top Markets
#1 Islamic Coin Islamic Coin +151.47%
#2 DOVU DOVU +49.95%
#3 Black Phoenix Black Phoenix +34.49%
#4 Velvet Velvet +32.46%
#5 Akedo Akedo +15.63%
#6 DoubleZero DoubleZero +13.65%
#7 HOME HOME +12.67%
#8 Cross Cross +12.27%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.90%
#10 Cap Cap +10.33%
Coin of the day
Islamic Coin Islamic Coin
Ρυθμίσεις
Γλώσσα
Ελληνικά
Νόμισμα
USD
Θέμα
Galera Therapeutics, Inc. Galera Therapeutics, Inc.

Galera Therapeutics, Inc.

GRTX
Κατάταξη σε μετοχές #33957
Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation and commercialization of therapies aimed at revolutionizing cancer radiotherapy. Its lead investigational drug, avasopasem manganese (GC4419), functions as a small molecule superoxide dismutase mimetic. This compound has successfully completed a Phase III clinical trial targeting severe oral mucositis induced by radiation therapy in head and neck cancer (HNC) patients. Furthermore, GC4419 is currently undergoing Phase IIa clinical trials for radiotherapy-induced esophagitis in lung cancer patients, as well as for HNC patients undergoing standard-of-care radiation treatment. The company is also progressing with GC4711, another superoxide dismutase mimetic candidate, which is in a Phase I/II clinical trial. This trial evaluates its combination with stereotactic body radiation therapy (SBRT) for individuals diagnosed with non-small cell lung cancer and locally advanced pancreatic cancer. Galera Therapeutics was founded in 2012 and maintains its headquarters in Malvern, Pennsylvania.
Τιμή μετοχής
$17.15
Τελευταίος συγχρονισμός: 2026-08-03
Κεφαλαιοποίηση
$6.51M
Αλλαγή (1 ημέρα)
9.80%
Αλλαγή (1 έτος)
289.77%
Χώρα
US
Εμπόριο Galera Therapeutics, Inc. (GRTX)

Κατηγορία

Healthcare
Δείκτης P/S για Galera Therapeutics, Inc. (GRTX)
Δείκτης P/S στις August 2026 TTM: 0.00
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Galera Therapeutics, Inc., ο τρέχων δείκτης P/S (TTM) είναι 0.00. Στο τέλος του 2023, ο δείκτης ήταν 0.00.
Ιστορικό P/S για την Galera Therapeutics, Inc. από 2017 έως 2026
Δείκτης P/S στο τέλος κάθε έτους
Έτος P/S Ratio Αλλαγή
2026 (TTM) 0.00 0.00%
2024 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
Δείκτης P/S για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία P/S Ratio Διαφορά P/S Ratio Χώρα
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 -
BE